Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home


 

Appendix F

Abbreviations used in this report
 

ACIP Advisory Committee on Immunization Practices
ap acellular pertussis vaccine (without tetanus and diphtheria toxoids)
B. bronchiseptica Bordetella bronchiseptica
B. holmesii Bordetella holmesii
B. parapertussis Bordetella parapertussis
B. pertussis Bordetella pertussis
C. diphtheriae Corynebacterium diphtheriae
C. tetani Clostridium tetani
C. ulcerans Corynebacterium ulcerans
CI confidence interval
CSTE Council of State and Territorial Epidemiologists
DFA direct fluorescent antibody
DT pediatric diphtheria and tetanus toxoids vaccine
DTaP pediatric diphtheria and tetanus toxoids and acellular pertussis vaccine
DTP pediatric diphtheria and tetanus toxoids and whole cell pertussis vaccine
EU ELISA units
ELISA enzyme-linked immunosorbent assay
ELS extensive limb swelling
FDA Food and Drug Administration
FHA filamentous hemagglutinin
FIM fimbriae
GMC geometric mean antibody concentration
GMT geometric mean titer
GSK GlaxoSmithKline Biologicals
HAI haemagglutinin inhibition
HIV human immunodeficiency virus
IM intramuscularly
IOM Institute of Medicine
IU international units
Lf limit of flocculation unit
MCV4 tetravalent meningococcal conjugate vaccine
MDPH Massachusetts Department of Public Health
mIU milli-international unit
mL milliliter
MPHBL Massachusetts Public Health Biologic Laboratories
ng nanogram
NNDSS National Notifiable Diseases Surveillance System
NHANES National Health and Nutritional Examination Survey
PCR  polymerase chain reaction
2-PE 2-phenoxyethanol
PRN pertactin
PPD tuberculin purified protein derivative
PT pertussis toxin
QALY quality adjusted life year
SAE serious adverse event
sp sanofi pasteur
SPSS Supplemental Pertussis Surveillance System
Tdap tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine
Td adult tetanus and diphtheria toxoids vaccine
TIG tetanus immune globulin
TIV  trivalent inactivated influenza vaccine
TT tetanus toxoid vaccine
VAERS Vaccine Adverse Event Reporting System
VICP Vaccine Injury Compensation Program
µg microgram

 

Advisory Committee on Immunization Practices Pertussis Working Group

Chair: Jon Abramson, MD, Winston-Salem, North Carolina.

Members: Guthrie Birkhead, MD, Albany, New York; Karen Broder, MD, Atlanta, Georgia; Dennis Brooks, MD, Baltimore, Maryland; Angela Calugar, MD, Atlanta, Georgia; Richard Clover, MD, Louisville, Kentucky; James Cheek, MD, Albuquerque, New Mexico; Margaret Cortese, MD, Atlanta, Georgia; Shelly Deeks, MD, Toronto, Ontario, Canada; Lorraine Duncan, Portland, Oregon; Geoffrey Evans, MD, Rockville, Maryland; Theresa Finn, PhD, Rockville, Maryland; Stanley Gall, MD, Louisville, Kentucky; Steve Gordon, MD, Cleveland, Ohio; Janet Gilsdorf, MD, Ann Arbor, Michigan; John Iskander, MD, Atlanta, Georgia; David Klein, PhD, Bethesda, Maryland; Katrina Kretsinger, MD, Atlanta, Georgia; Susan Lett, MD, Boston, Massachusetts; Sara Long, MD, Philadelphia, Pennsylvania; Bruce Meade, PhD, Rockville, Maryland; Julie Morita, MD, Chicago, Illinois; Trudy Murphy, MD, Atlanta, Georgia; Stephen Phillips, DO, Falls Church, Virginia; Margaret Rennels, MD, Baltimore, Maryland; Robert Scalettar, MD, North Haven, Connecticut; William Schaffner, MD, Nashville, Tennessee; Ann Schwartz, MD, Rockville Maryland; Barbara Slade, MD, Atlanta, Georgia; Tejpratap Tiwari, MD, Atlanta, Georgia; Gregory Wallace, MD, Atlanta, Georgia.

Advisory Committee on Immunization Practices
Membership List, June 2005

Chairman: Myron J. Levin, MD, University of Colorado Health Sciences Center, Denver, Colorado.

Executive Secretary: Larry K. Pickering, MD, Senior Advisor to the Director, National Immunization Program, CDC, Atlanta, Georgia.

Members: Jon S. Abramson, MD, Wake Forest University School of Medicine, Winston-Salem, North Carolina; Ban Mishu Allos, MD, Vanderbilt University School of Medicine, Nashville, Tennessee; Guthrie S. Birkhead, MD, New York State Department of Health, Albany, New York; Judith Campbell, MD, Baylor College of Medicine, Houston, Texas; Reginald Finger, MD, Focus on the Family, Colorado Springs, Colorado; Janet R. Gilsdorf, MD, University of Michigan, Ann Arbor, Michigan; Tracy Lieu, MD, Harvard Pilgram Healthcare and Harvard Medical School, Boston, Massachusetts; Edgar K. Marcuse, MD, Children's Hospital and Regional Medical Center, Seattle, Washington; Julie Morita, MD, Chicago Department of Public Health, Chicago, Illinois; Gregory A. Poland, MD, Mayo Medical School, Rochester, Minnesota; John B. Salamone, National Italian American Foundation, Washington, D.C.; Patricia, Stinchfield, MS, Children's Hospitals and Clinics, St. Paul, Minnesota; John J. Treanor, MD, University of Rochester School of Medicine and Dentistry, Rochester, New York; and Robin J. Womeodu, MD, University of Tennessee Health Sciences Center, Memphis, Tennessee.

Ex-Officio Members: James E. Cheek, MD, Indian Health Service, Albuquerque, New Mexico; Wayne Hachey, DO, Department of Defense, Falls Church, Virginia; Geoffrey S. Evans, MD, Health Resources and Services Administration, Rockville, Maryland; Bruce Gellin, MD, National Vaccine Program Office, Washington, DC; Linda Murphy, Centers for Medicare and Medicaid Services, Baltimore, Maryland; George T. Curlin, MD, National Institutes of Health, Bethesda, Maryland; Norman Baylor, PhD, Office of Vaccines Research Review, Rockville, Maryland; Kristin Lee Nichol, MD, Department of Veterans Affairs, Minneapolis, Minnesota.

Liaison Representatives: Jonathan Temte, MD, Madison, Wisconsin, Richard D. Clover, MD, Louisville, Kentucky, American Academy of Family Physicians; Margaret Rennels, MD, Baltimore, Maryland, Carol Baker, MD, Houston, Texas, American Academy of Pediatrics; Andrea Gelzer, MD, Hartford, Connecticut, America's Health Insurance Plans; James C. Turner, MD, Charlottesville, Virginia, American College Health Association; Stanley Gall, MD, Louisville, Kentucky, American College of Obstetricians and Gynecologists; Kathleen M. Neuzil, MD, Seattle, Washington, American College of Physicians; Litjen Tan, PhD, Chicago, Illinois, American Medical Association; Stephan L. Foster, PharmD, Memphis, Tennessee, American Pharmacists Association; W. Paul McKinney, MD, Louisville, Kentucky, Association of Teachers of Preventive Medicine; Clement Lewin, PhD, Orange, Connecticut, Biotechnology Industry Organization; Monika Naus, MD, Vancouver, British Columbia, Canada, Canadian National Advisory Committee on Immunization; Steve Gordon, MD, Cleveland, Ohio, Healthcare Infection Control Practices Advisory Committee, Samuel L. Katz, MD, Durham, North Carolina, and William Schaffner, MD, Nashville, Tennessee, Infectious Diseases Society of America; David M. Salisbury, MD, London, United Kingdom, London Department of Health; Nancy Bennett, MD, Rochester, New York, National Association of County and City Health Officials; David A. Neumann, PhD, Alexandria, Virginia, National Coalition for Adult Immunization; Romeo Rodriguez, Mexico City, Mexico, National Immunization Council and Child Health Program; Dennis A. Brooks, MD, Baltimore, Maryland, National Medical Association; Charles Helms, MD, Iowa City, Iowa, National Vaccine Advisory Committee; Amy B. Middleman, MD, Houston, Texas, Society for Adolescent Medicine; Damian A. Braga, MBA, Swiftwater, Pennsylvania, Peter Paradiso, PhD, Collegeville, Pennsylvania, Pharmaceutical Research and Manufacturers of America.

Preventing Tetanus, Diphtheria, and Pertussis Among Adolescents: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
 



Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.

References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.


All MMWR HTML versions of articles are electronic conversions from typeset documents. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (http://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.

**Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.

 
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #